TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33496068

Group type: EXPERIMENTAL
Intervention: Candida antigen (0.1 mL of Candida albicans antigen injected monthly in one patch of alopecia)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Intralesional corticosteroid (0.1 mL of triamcinolone acetonide injected monthly in all alopecia patches)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Candida antigen
Number of subjects: 48

Group type: COMPARATOR
Intervention: Intralesional corticosteroid
Number of subjects: 48
Study: 33023521

Group type: EXPERIMENTAL
Intervention: Guided counseling (monthly for four consecutive months)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Guided counseling (direct effect)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Guided counseling (indirect effect)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Control group (routine nutrition education)
Number of subjects: 258
Study: 33400792

Group type: EXPERIMENTAL
Intervention: Ad26.RSV.preF
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 34184130

Group type: EXPERIMENTAL
Intervention: Lorazepam plus haloperidol
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo plus haloperidol
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: RASS improvement
Number of subjects: 58
Study: 32315537

Group type: EXPERIMENTAL
Intervention: Antidepressant Treatment Record (ATR) classification level 1
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Antidepressant Treatment Record (ATR) classification level 2
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Antidepressant Treatment Record (ATR) classification level ≥3
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Treatment with serotonin norepinephrine reuptake inhibitors (SNRIs)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Treatment with dopamine norepinephrine reuptake inhibitors (DNRIs)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Treatment with mixed dopamine serotonin receptor antagonists
Number of subjects: 97
Study: 36497905

Group type: EXPERIMENTAL
Intervention: Pressure injury E‐book app training program
Number of subjects: 164

Group type: COMPARATOR
Intervention: Conventional education program
Number of subjects: 164
Study: 32950546

Group type: EXPERIMENTAL
Intervention: Calcipotriene 0.005%/betamethasone dipropionate 0.064% foam (Cal/BD)
Number of subjects: 545

Group type: COMPARATOR
Intervention: Vehicle foam (reactive management)
Number of subjects: 545
Study: 32677499

Group type: EXPERIMENTAL
Intervention: Video group (video simulation of seizure first aid)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Standard counseling group (standard verbal counseling)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Standard counseling group (among families without baseline knowledge)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Video group (among families without baseline knowledge)
Number of subjects: 83
Study: 35707522

Group type: EXPERIMENTAL
Intervention: Integrative Acupuncture and Moxibustion (iAM) treatment
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Sertraline (50 mg once a day)
Number of subjects: 592

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Active/sham iAM treatment (three times per week)
Number of subjects: 592
Study: 34283799

Group type: EXPERIMENTAL
Intervention: Classical music played during treatment
Number of subjects: 222

Group type: COMPARATOR
Intervention: No music played during treatment
Number of subjects: 222
Study: 32085706

Group type: EXPERIMENTAL
Intervention: TAU+WASH
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: TAU+WASH+SUPPORT
Number of subjects: 495

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 495
Study: 34196048

Group type: EXPERIMENTAL
Intervention: MFPSS programme plus routine care
Number of subjects: 42

Group type: COMPARATOR
Intervention: Routine care only
Number of subjects: 42
Study: 33779064

Group type: EXPERIMENTAL
Intervention: Allopurinol (300 mg daily)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 33218524

Group type: EXPERIMENTAL
Intervention: Daily aerobic walking exercise (DAWE)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sedentary lifestyle (Control Group)
Number of subjects: 54
Study: 36291940

Group type: EXPERIMENTAL
Intervention: US‐NAB with ROSE
Number of subjects: 136

Group type: COMPARATOR
Intervention: US‐NAB without ROSE
Number of subjects: 136
Study: 32166831

Group type: EXPERIMENTAL
Intervention: Clonidine (3 µg/kg intravenous bolus)
Number of subjects: 18
Study: 32173808

Group type: COMPARATOR
Intervention: Ropivacaine (R) 2mg/kg with ropivacaine: 4.75 mg/ml in wound infiltration (WI)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ropivacaine and Dexmedetomidine (RD) 2mg/kg of ropivacaine and 0.5 ug/kg of DEX
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ropivacaine (R)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ropivacaine and Dexmedetomidine (RD)
Number of subjects: 100
Study: 33435969

Group type: EXPERIMENTAL
Intervention: Single incentive for HbA1c reduction at 3 months (Group 1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Two-part equal incentive for home testing of glucose and HbA1c reduction at 3 months (Group 2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Three-part equal incentive for home testing, attendance of weekly telephone education classes, and HbA1c reduction at 3 months (Group 3)
Number of subjects: 60
Study: 35927806

Group type: EXPERIMENTAL
Intervention: Active 10Hz rTMS (n=63)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Sham stimulation (n=46)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Active 10Hz rTMS (n=63) in CC homozygotes
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Active 10Hz rTMS (n=63) in T allele carriers
Number of subjects: 109
Study: 32979880

Group type: EXPERIMENTAL
Intervention: Combined screening programme including a risk‐assessment questionnaire and rapid tests for point‐of‐care diagnosis
Number of subjects: 7991

Group type: COMPARATOR
Intervention: Educational intervention only (control)
Number of subjects: 7991

Group type: EXPERIMENTAL
Intervention: Combined screening programme
Number of subjects: 7991
Study: 36082412

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Light Dark Therapy (LDT)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Treatment-as-Usual (TAU)
Number of subjects: 114
Study: 34477119

Group type: EXPERIMENTAL
Intervention: Reminiscence therapy
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study: 33002437

Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy (64 Gy in 32 fractions)
Number of subjects: 333

Group type: COMPARATOR
Intervention: Salvage radiotherapy (64 Gy in 32 fractions triggered by PSA of 0.20 ng/mL or more)
Number of subjects: 333
Study: 35809658

Group type: EXPERIMENTAL
Intervention: IOL oriented vertically
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: IOL oriented horizontally
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: IOL oriented superonasally
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: IOL oriented inferonasally
Number of subjects: 163

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 163
Study: 32609918

Group type: EXPERIMENTAL
Intervention: TMJ arthroscopy plus hyaluronic acid (HA)
Number of subjects: 51

Group type: COMPARATOR
Intervention: TMJ arthroscopy
Number of subjects: 51
Study: 32881903

Group type: EXPERIMENTAL
Intervention: Fibromyalgia (FM) group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fibromyalgia (FM) group with comorbidities (diabetes, hyperlipidemia, depression, Meniere’s disease)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-FM group
Number of subjects: 0
Study: 35913793

Group type: EXPERIMENTAL
Intervention: Preprocedural anxiety (assessed using State‐Trait Anxiety Inventory for Children)
Number of subjects: 90
Study: 34848508

Group type: EXPERIMENTAL
Intervention: Nasal high flow rhinothermy (rNHF) - 100% humidified air delivered at 35 L/min and 41°C for 2 hours daily for 5 days
Number of subjects: 170

Group type: COMPARATOR
Intervention: Sham rhinothermy - 100% humidified air delivered at 10 L/min and 31°C for 10 min daily for 5 days
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Nasal high flow rhinothermy (rNHF)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Sham rhinothermy
Number of subjects: 170
Study: 34587648

Group type: EXPERIMENTAL
Intervention: L-NMMA (NOS inhibitor)
Number of subjects: 14
Study: 35792453

Group type: EXPERIMENTAL
Intervention: Head-of-bed elevation to 45°
Number of subjects: 20

Group type: COMPARATOR
Intervention: No head-of-bed elevation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Clinical algorithm with head-of-bed elevation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Composite ultrasound scale
Number of subjects: 20
Study: 34142638

Group type: EXPERIMENTAL
Intervention: Tribulus terrestris 94mg, three times/day for 90 days (TT3)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Tribulus terrestris 280mg once/day for 90 days (TT1)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 104
Study: 32078891

Group type: EXPERIMENTAL
Intervention: TAU + AE
Number of subjects: 40

Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 40
Study: 33962601

Group type: COMPARATOR
Intervention: Mild physical activity
Number of subjects: 245

Group type: COMPARATOR
Intervention: Moderate and severe physical activity
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Higher BMI and body fat mass (BFM)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Lower lean body mass (LBM) and soft lean mass (SLM)
Number of subjects: 245
Study: 32276611

Group type: EXPERIMENTAL
Intervention: Micro-AF group (n=221)
Number of subjects: 3763

Group type: COMPARATOR
Intervention: Control group (n=250)
Number of subjects: 3763
Study: 33327985

Group type: EXPERIMENTAL
Intervention: Gloves
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Gloves plus gowns
Number of subjects: 30

Group type: COMPARATOR
Intervention: No barrier
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Gloves plus gowns with hand hygiene
Number of subjects: 30
Study: 32861569

Group type: EXPERIMENTAL
Intervention: IRE-FOLFIRINOX
Number of subjects: 52

Group type: COMPARATOR
Intervention: FOLFIRINOX-only
Number of subjects: 52
Study: 36063974

Group type: EXPERIMENTAL
Intervention: BoNT/A
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 33675264

Group type: EXPERIMENTAL
Intervention: Hemp-based nutraceutical product (Gs Formula; GF) at 160 g/day (LO)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Hemp-based nutraceutical product (Gs Formula; GF) at 480 g/day (HI)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Hemp-based nutraceutical product (Gs Formula; GF) at 0 g/day (CON)
Number of subjects: 8
Study: 32474979

Group type: EXPERIMENTAL
Intervention: Isometric calf-muscle exercises (tiptoes)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Isometric calf-muscle exercises (dorsiflexed ankle position)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Isotonic calf-muscle exercises
Number of subjects: 91

Group type: COMPARATOR
Intervention: Rest
Number of subjects: 91
Study: 35761341

Group type: EXPERIMENTAL
Intervention: Indwelling pleural catheter (IPC)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Video-assisted thoracoscopic surgery (VATS) pleurodesis
Number of subjects: 158
Study: 34082113

Group type: EXPERIMENTAL
Intervention: Flipped classroom
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Flipped classroom (exotropia)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Traditional classroom (esotropia)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Flipped classroom (esotropia)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Traditional classroom (exotropia)
Number of subjects: 110
Study: 32791704

Group type: EXPERIMENTAL
Intervention: Sogyeonghwalhyeol-tang (SGHH) alone
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Sogyeonghwalhyeol-tang (SGHH) with Chuna manual therapy (CMT)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo with Chuna manual therapy (CMT)
Number of subjects: 150
Study: 35167764

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (25,000 IU weekly)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Nothing (control group)
Number of subjects: 90
Study: 34914293

Group type: EXPERIMENTAL
Intervention: NNN linkages-based standardized nursing language
Number of subjects: 96

Group type: COMPARATOR
Intervention: Routine nursing
Number of subjects: 96
Study: 35586992

Group type: EXPERIMENTAL
Intervention: VPT-lecture combined with a VPT-laboratory (experimental group)
Number of subjects: 108

Group type: COMPARATOR
Intervention: VPT lecture-only (control group)
Number of subjects: 108
Study: 34274600

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Selective Serotonin Reuptake Inhibitor (SSRI)
Number of subjects: 96
Study: 32019428

Group type: EXPERIMENTAL
Intervention: aCPAP plus usual care
Number of subjects: 3062

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 3062
Study: 35062907

Group type: EXPERIMENTAL
Intervention: Nutritional intervention (one egg per day for 6 months)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Multicomponent Grandi Byen intervention (responsive parenting, nutrition, WASH + one egg per day for 6 months)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard well-baby care
Number of subjects: 600
Study: 34900185

Group type: EXPERIMENTAL
Intervention: Chrysanthemum extract 400 mg/day (200 mg/day, twice/day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard stroke treatment
Number of subjects: 46
Study: 36459070

Group type: EXPERIMENTAL
Intervention: Subtalar joint mobilization with movement (STJ MWM)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (neurodevelopmental treatment and talocrural joint MWM)
Number of subjects: 28
Study: 33615468

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol
Number of subjects: 88

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 88
Study: 33267762

Group type: EXPERIMENTAL
Intervention: Intravitreal Dexamethasone implant (IVD) 0.7 mg, single dose
Number of subjects: 140

Group type: COMPARATOR
Intervention: Intravitreal Ranibizumab injection (IVR) 0.3 mg, 3 doses (monthly)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Intravitreal Dexamethasone implant (IVD)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Intravitreal Ranibizumab injection (IVR)
Number of subjects: 140
Study: 35879205

Group type: EXPERIMENTAL
Intervention: V-flap technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Slit-artreriotomy group
Number of subjects: 20
Study: 34021118

Group type: EXPERIMENTAL
Intervention: Rd with clarithromycin (C-Rd)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Rd without clarithromycin (Rd)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: C-Rd
Number of subjects: 286

Group type: COMPARATOR
Intervention: Rd
Number of subjects: 286
Study: 33631355

Group type: EXPERIMENTAL
Intervention: Denosumab (60 mg/6 months)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Alendronate (70 mg/week)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 139

Group type: COMPARATOR
Intervention: Alendronate
Number of subjects: 139

Group type: COMPARATOR
Intervention: Denosumab and Alendronate
Number of subjects: 139
Study: 32282491

Group type: EXPERIMENTAL
Intervention: Aromatherapy (lavender oil) inhalation administered half hour before sleep every day for a month.
Number of subjects: 59

Group type: COMPARATOR
Intervention: No administration applied to the control group.
Number of subjects: 59
Study: 35830078

Group type: EXPERIMENTAL
Intervention: Robotic-assisted thoracic surgery (RATS)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Video-assisted thoracic surgery (VATS)
Number of subjects: 76
Study: 33908306

Group type: EXPERIMENTAL
Intervention: Hispanic families
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-Hispanic families
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Change in coping strategies
Number of subjects: 0
Study: 32492157

Group type: EXPERIMENTAL
Intervention: Early prophylaxis
Number of subjects: 37

Group type: COMPARATOR
Intervention: Delayed prophylaxis
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Prophylaxis
Number of subjects: 37
Study: 33704366

Group type: EXPERIMENTAL
Intervention: itMatters intervention
Number of subjects: 3098

Group type: EXPERIMENTAL
Intervention: SVP component
Number of subjects: 3098
Study: 33049709

Group type: EXPERIMENTAL
Intervention: Estradiol therapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 36422204

Group type: EXPERIMENTAL
Intervention: Topical dexamethasone (1 mg/mL)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Topical bromfenac (0.9 mg/mL)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 34555822

Group type: EXPERIMENTAL
Intervention: Active stimulation
Number of subjects: 59

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 59
Study: 32066489

Group type: EXPERIMENTAL
Intervention: Ticagrelor (loading dose 180 mg, maintenance dose 90 mg bid)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Clopidogrel (loading dose 600 mg, maintenance dose 75 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 100

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 100
Study: 35150621

Group type: EXPERIMENTAL
Intervention: Low-cost behavioural intervention including folk performance, transect walk, community meeting, recognition banners, community wall painting, mothers’ meetings, household visits, and latrine repairs.
Number of subjects: 3723

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 3723

Group type: EXPERIMENTAL
Intervention: Low-cost behavioural intervention.
Number of subjects: 3723
Study: 34167675

Group type: EXPERIMENTAL
Intervention: Intravascular lithotripsy (IVL)
Number of subjects: 306

Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 306
Study: 36146909

Group type: EXPERIMENTAL
Intervention: Educational intervention (informational handouts and videos about health effects of juice and SSBs)
Number of subjects: 144
Study: 33915812

Group type: EXPERIMENTAL
Intervention: Technology-based intervention for self-management behaviors
Number of subjects: 0
Study: 36281763

Group type: COMPARATOR
Intervention: Clinic-based care using best practices and face-to-face visits with physicians and medical assistants
Number of subjects: 3071

Group type: EXPERIMENTAL
Intervention: Telehealth care using best practices and home BP telemonitoring with home-based care coordinated by a clinical pharmacist or nurse practitioner
Number of subjects: 3071

Group type: EXPERIMENTAL
Intervention: Telehealth care
Number of subjects: 3071
Study: 33655799

Group type: EXPERIMENTAL
Intervention: Weekly aerobic exercises associated with nutritional counseling
Number of subjects: 58

Group type: COMPARATOR
Intervention: Usual care with nutritional counseling
Number of subjects: 58
Study: 33936350

Group type: EXPERIMENTAL
Intervention: remifentanil/propofol (group P)
Number of subjects: 60

Group type: COMPARATOR
Intervention: remifentanil/sevoflurane (group S)
Number of subjects: 60
Study: 32271583

Group type: EXPERIMENTAL
Intervention: Ultraviolet-Ozone (UVO) treatment applied to drug-coated balloons (DCBs) with urea-paclitaxel coating.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard drug-coated balloons (DCBs) without UVO treatment.
Number of subjects: 0
Study: 35213106

Group type: EXPERIMENTAL
Intervention: Powered Endoscopic Turbinoplasty (PET)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Partial Inferior Turbinectomy (PIT)
Number of subjects: 50
Study: 34215519

Group type: EXPERIMENTAL
Intervention: Standardized visual assessment (5-point bleeding score)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ROTEM® measurements
Number of subjects: 0
Study: 33028395

Group type: EXPERIMENTAL
Intervention: Persistent HPV16 infection
Number of subjects: 96

Group type: COMPARATOR
Intervention: Transient HPV16 infection
Number of subjects: 96

Group type: COMPARATOR
Intervention: HPV negative women
Number of subjects: 96
Study: 36198841

Group type: EXPERIMENTAL
Intervention: Labels: lumbar sprain, non-specific low back pain, episode of back pain
Number of subjects: 1447

Group type: COMPARATOR
Intervention: Labels: disc bulge, degeneration, arthritis
Number of subjects: 1447

Group type: EXPERIMENTAL
Intervention: Labels: non-specific LBP, episode of back pain
Number of subjects: 1447
Study: 34587702

Group type: EXPERIMENTAL
Intervention: Low dose red yeast rice (200 mg/day) containing 2 mg monacolin K
Number of subjects: 18

Group type: COMPARATOR
Intervention: Diet therapy alone
Number of subjects: 18
Study: 32764818

Group type: EXPERIMENTAL
Intervention: Active workstation (treadmill or cycling desk)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Seated session
Number of subjects: 137
Study: 33734864

Group type: EXPERIMENTAL
Intervention: 2.5 mg tamoxifen
Number of subjects: 1439

Group type: EXPERIMENTAL
Intervention: 5 mg tamoxifen
Number of subjects: 1439

Group type: EXPERIMENTAL
Intervention: 10 mg tamoxifen
Number of subjects: 1439

Group type: COMPARATOR
Intervention: 20 mg tamoxifen
Number of subjects: 1439
Study: 34737863

Group type: EXPERIMENTAL
Intervention: Intervention (community health workers and Ethiopian Orthodox priests providing outreach and counseling)
Number of subjects: 18
Study: 36064438

Group type: EXPERIMENTAL
Intervention: AutoKinetics dosing for ciprofloxacin
Number of subjects: 252

Group type: COMPARATOR
Intervention: Standard dosing for ciprofloxacin (Control)
Number of subjects: 252
Study: 33836830

Group type: COMPARATOR
Intervention: Caucasian prediction equation
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Ethiopian ethnic-specific BF% prediction equation
Number of subjects: 704
Study: 34265777

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBTi) followed by Cognitive Processing Therapy (CPT)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Attention Control followed by Cognitive Processing Therapy (CPT)
Number of subjects: 110
Study: 32380012

Group type: EXPERIMENTAL
Intervention: Screening for IPV by health care professionals
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Compassionate care in IPV screening
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Awareness of dynamic responses of IPV survivors
Number of subjects: 17